In 2025, the healthcare industry stands at the forefront of transformation, shaped by evolving regulations, shifting payment models, and shifting patient priorities. At Ochsner Health, we understand ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) could improve patient adherence and simplify treatment ...

A dual-compound strategy rewires the injured spinal cord. This graphic shows how a paired therapy combining luteolin (Lut) and astragaloside IV (AST)—two bioactive compounds derived from the ...

Spread the loveIn a groundbreaking study, researchers from the Tokyo University of Science have revealed a remarkable synergy between common plant compounds that may hold the key to enhanced ...

Spinal cord injury remains one of the most challenging neurological conditions to treat, largely because damage continues to worsen long after the initial trauma. Secondary injury processes—driven by ...